Centro di Ricerca "E. Menni", Fondazione Poliambulanza Istituto Ospedaliero , Brescia , Italy.
Front Bioeng Biotechnol. 2015 Oct 19;3:162. doi: 10.3389/fbioe.2015.00162. eCollection 2015.
In the 1800s, a baby born with a caul, a remnant of the amniotic sack or fetal membranes, was thought to be lucky, special, or protected. Over time, fetal membranes lost their legendary power and were soon considered nothing more than biological waste after birth. However, placenta tissues have reclaimed their potential and since the early 1900s an increasing body of evidence has shown that these tissues have clinical benefits in a wide range of wound repair and surgical applications. Nowadays, there is a concerted effort to understand the mechanisms underlying the beneficial effects of placental tissues, and, more recently, cells derived thereof. This review will summarize the historical and current clinical applications of human placental tissues, and cells isolated from these tissues, and discuss some mechanisms thought to be responsible for the therapeutic effects observed after tissue and/or cell transplantation.
在 19 世纪,一个出生时带有胎膜(羊膜囊或胎儿膜的残留物)的婴儿被认为是幸运的、特别的或受到保护的。随着时间的推移,胎膜失去了它们的传奇力量,很快就被认为只是出生后的生物废物。然而,胎盘组织重新获得了它们的潜力,自 20 世纪初以来,越来越多的证据表明,这些组织在广泛的伤口修复和手术应用中具有临床益处。如今,人们正在努力了解胎盘组织及其衍生细胞有益作用的机制,最近,人们还研究了这些细胞。本文将总结人类胎盘组织及其分离细胞的历史和当前临床应用,并讨论一些被认为是组织和/或细胞移植后观察到治疗效果的机制。